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ORIGINAL ARTICLE
Next-generation sequencing of whole saliva from patients with primary
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Medical Sciences, University of Copenhagen, Copenhagen, Denmark; cDepartment of Rheumatology, Frederiksberg Hospital, University
of Copenhagen, Copenhagen, Denmark; dInstitute for Inflammation Research, Center for Rheumatology and Spine Diseases,
Copenhagen University Hospital, Copenhagen, Denmark
ABSTRACT
Objective:To characterize and compare the salivary microbiota in patients with pSS and
patients with non-Sjögren’s-related sicca, and to relate the findings to their oral health status
and saliva flow rates.
Methods:Twenty-four patients fulfilled the 2016 classification criteria for pSS and 34 did not (non-
pSS). A clinical examination included registration of decayed, missing and filled teeth/-surfaces and
collection of whole saliva. The microbiota was characterized using next-generation sequencing of
the V1–V3 region of the 16S rRNA gene. Data were annotated against the eHOMD database.
Results:A total of 509 different bacterial taxa were identified. There were no statistically
significant differences between the groups with regard to the abundance of predominant
genera, bacterial diversity and relative abundance on the genus or species level. The two
groups did not differ with regard to general health, including intake of xerogenic medication
and polypharmacy, oral health status or unstimulated and stimulated whole saliva flow rates.
Conclusion: The salivary microbiota and oral health status, as well as salivary flow rate in
patients with pSS resemble that of non-pSS patients. Our findings indicate that changes in
the salivary microbiota do not appear to be determined by the disease entity pSS itself.
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Primary Sjögren’s syndrome (pSS) is a rheumatic auto-
immune disease of unknown aetiology, which is charac-
terized by lymphocytic infiltration of exocrine glands. It
is particularly the salivary and lacrimal glands that are
affected leading to hyposalivation and keratoconjuncti-
vitis sicca and severe symptoms of oral and ocular dry-
ness [1].
Saliva is a biological fluid, which has been widely
investigated as a diagnostic medium, and several differ-
ent salivary biomarkers have been suggested for pSS [2].
Additionally, saliva plays an important role in the main-
tenance of a natural balance between the host and the
oral microbiota, which becomes evident in conditions
with salivary gland dysfunction [3,4]. At low saliva flow
rates, the salivary bicarbonate concentration drops, caus-
ing a reduction in salivary pH, and impairment of the
salivary buffer capacity and clearance [5]. This can lead
to a shift in the oral microbiota promoting colonization
and growth of aciduric and acidogenic microorganisms,
which increases the susceptibility for developing dental
caries and oral candidiasis [5–7]. It has previously been
shown that patients with pSS have a higher number of
decayed, missing and filled teeth (DMF-T), as well as oral
fungal infections, compared to healthy control subjects
[7–11]. On the other hand, the risk of developing period-
ontitis does not appear to be higher in pSS [4,12].
Previous culture-based studies have shown higher
counts of Lactobacillus and Streptococcus mutans in
plaque and saliva from patients with pSS, and in
patients with medication- and radiotherapy-induced
hyposalivation, compared to healthy control subjects
[13–17]. However, the use of culture-based microbial
technique and selective media for identifying specific
oral microorganisms has limitations and only display
a minor fraction of the total oral microbiota found in
the oral cavity [18,19].
A more recent study using high throughput sequen-
cing of the 16S rRNA gene has shown that reduced
salivary secretion is associated with a bacterial shift in
oral washings, while low relative abundance of
Streptococcus was reported as being potentially disease-
specific for pSS, irrespective of saliva flow rate and in
comparison with sicca control and healthy control sub-
jects [20]. Zhou et al. found a significantly higher relative
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abundance of Veillonella species in patients with pSS
than in healthy control subjects, but no differences with
regard to Streptococcus and Lactobacillus species [11]. On
the other hand, Siddiqui et al. found a higher proportion
of Firmicutes and Streptococcus species and a lower pro-
portion of Synergistetes and Spirochetes in unstimulated
whole saliva from pSS patients with saliva flow rates
within the normal range compared to healthy control
subjects. The authors suggest that pSS itself is associated
with a characteristic microbial shift independent of
hyposalivation [18]. Furthermore, our group has recently
found a comparable salivary microbiota in patients with
hyposalivation and patients with normal saliva flow rates,
when both groups had comparable DMF-T and no active
caries lesions present. This indicates that oral health
status is a stronger determinant of the oral microbiota
than the whole saliva flow rate per se [21].
Although there are few indications of a shift in the
composition of the oral microbiota in pSS, it remains
unclear whether this occurs as a result of pSS itself or
more likely to occur as a result of disease-associated
reduced salivary secretion. Moreover, it is unclear
whether a specific shift in the oral microbiota makes
patients with pSS more susceptible to develop oral
and dental disease than patients with reduced salivary
secretion of other causes.
We hypothesized that patients with pSS have
a distinct salivary microbiota related to their salivary
flow rates and reflected in a poorer oral health status
compared to non-Sjögren’s syndrome-related sicca
controls. The aim of this study was, therefore, to
characterize and compare the microbiota in stimu-
lated whole saliva samples from patients with pSS and
patients with non-Sjögren’s syndrome-related sicca
by means of next-generation sequencing (NGS).
Furthermore, the aim was to compare the oral health
status and saliva flow rates in the two groups.
Methods and materials
Study population
A total of 66 patients were screened of whom 62 were
eligible for enrollment in the study. The inclusion
criteria comprised the age from 18 to 75 years and
the presence of symptoms of oral and/or ocular dry-
ness. Exclusion criteria included pregnant and nur-
sing women, use of local or systemic antibiotics 3
months prior to the examination and presence of
secondary Sjögren’s syndrome. Four samples failed
during the NGS analysis. Therefore, 58 patients
were included in the study.
The patients were consecutively referred from rheu-
matology or ophthalmology out-patient clinics, private
practising rheumatologists or dentists when a diagnosis
of pSS was suspected. The patients underwent
a diagnostic workup in accordance with the American
College of Rheumatology/European League Against
Rheumatism (ACR-EULAR) classification criteria
[22]. Twenty-four patients fulfilled the ACR-EULAR
classification criteria for pSS, while 34 patients (non-
pSS) did not.
The study was conducted in accordance with the
Declaration of Helsinki for experiments involving
humans and approved by the Ethical Committees
for the Region of Copenhagen, Denmark
(H-160321 September 5289, 2016). Prior to the exam-
ination, all patients received oral and written infor-
mation and written informed consent was obtained.
The Danish Data Protection Authority has approved
the establishment of a research biobank.
Clinical examination and interview
The oral clinical examinations and collection of sam-
ples were performed by one examiner (MLSM) with
assistance from a senior investigator (AMLP) from
October 2016 through December 2017 at the Clinic of
Oral Medicine, Department of Odontology at the
University of Copenhagen. To avoid influence from
diurnal variations in saliva secretion all procedures
were performed at the same time of the day
(10:00–12:00 a.m.). A standardized interview with
a questionnaire regarding general and oral health
was performed, including the presence of concomi-
tant systemic diseases, daily intake of prescribed med-
ication, symptoms of oral and ocular dryness,
extraglandular manifestations, tobacco use and alco-
hol consumption.
Clinical examination included registration of
DMF-T and -surfaces (DMF-S). Dental plaque, gin-
gival inflammation and periodontal pocket depth
were registered on six index teeth [23]. The oral
mucosa was inspected for structural changes and
external palpation of salivary glands and regional
lymph nodes was performed.
Measurement of saliva flow rates and collection
of whole saliva samples
Unstimulated whole saliva (UWS) and paraffin-chewing
stimulated whole saliva (SWS) flow rates were measured
for 15 and 5min, respectively, using the drainingmethod
[24]. Hyposalivation was defined as UWS ≤ 0.1 ml/min
and SWS ≤ 0.7 ml/min (only UWS measurements were
used for diagnostic workup), while a UWS flow rate at
0.3–0.4 ml/min and an SWS flow rate at 1.5–2.0 ml/min
were considered the normal range [4].
Immediately after measurement of the SWS flow rate,
each saliva sample was divided into different aliquots and
placed on dry ice followed by storage in a −80°C freezer
until further analyses. Bacterial characterization was
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performed using DNA-based identification with Human
Oral Microbe Identification using Next Generation
Sequencing (HOMINGS).
Sample preparation for NGS
The DNA extraction was carried out with 400 µl of
chewing-stimulated whole saliva from all 62 patients,
which was mixed thoroughly with 50 µl of a 50 mg/ml
lysozyme solution (Cat. #90,082, ThermoFisher,
Roskilde, Denmark) and incubated for 2 h at 37°C.
Two samples failed due to too small volume and
a deficient concentration of DNA. The entire sample
was subsequently purified using the Maxwell 16 Cell
DNA Purification Kit (Cat.# AS1020, Promega,
Wisconsin) as instructed by the manufacturer.
Purified DNA was measured using the Qubit dsDNA
high-sensitivity kit (Cat. #Q32854, ThermoFisher,
Roskilde) and normalized to 20 ng/µl.
NGS and taxonomic assignment
HOMINGS analysis was performed at the Forsyth
Institute, Cambridge, MA. Sixty samples went
through quality control by measuring DNA concen-
tration using NanoDrop. PCR-amplification was per-
formed with 50 ng (5 ng/µl in 10 µl) of the sample
DNA using custom universal 16S primers targeting
the highly conserved V1–V3 region of the 16S rRNA
gene. Purification was made using AMPure XP beads
(Beckman Coulter). Amplicons from 60 samples were
pooled in equal amounts of libraries into one tube
with 100 ng/library, followed by gel-purification
using the MinElute Gel Extraction Kit (Qiagen).
Then, quantification using NEBNext Library Quant
Kit and sequencing with Illumina® MiSeqTM were
performed. Two samples failed sequencing due to
less than 7,500 reads (cut-off).
Data analyses
The demographic and clinical data in Table 1 were pro-
cessed in SPSS software and compared using unpaired
t-test if data showed a normal distribution and non-
parametric Mann–Whitney U test if not. Categorical
data were tested with Fisher’s exact test. A P-value <0.05
was considered statistically significant for all purposes.
Raw files were processed using the DADA2 R package
to identify and quantify the sequencing reads from the
MiSeq software [25]. Taxonomy of the identified ampli-
con sequence variants was assigned using the RDP clas-
sifier algorithm [26] based on the eHOMDdatabase [27].
The salivary bacterial composition was characterized and
compared between the two groups by means of principal
component and correspondence analysis andwith regard
to relative abundance and bacterial diversity. The analysis
was carried out using the Mann–Whitney U test with
Benjamini Hochberg’s correction for multiple dependent
analyses. For these analyses, MeV version 4_9_0 and
GraphPad Prism version 5 were used as statistical
software.
Results
Demographic and clinical characteristics of
patients
Table 1 summarizes the demographic data and the clin-
ical characteristics of the patients. There were no statisti-
cally significant differences between the two groups with
regard to age, smoking status and intake of xerogenic
Table 1. Demographic and clinical data of pSS and non-pSS patients.
pSS (n = 24) non-pSS (n = 34) p Value < 0.05
Age (Years)§ 56 ± 10 54 ± 15 N.S.
Gender (F/M) 22/2 30/4 N.S.
Current smoker (yes/no) 6/18 7/27 N.S.
No. of prescribed medications* 1 (0–4) 1 (0–11) N.S.
Polypharmacy (≥5) (yes/no) 0/24 5/29 N.S.
No. of xerogenic medications* 0 (0–1) 0 (0–4) N.S.
Xerostomia (yes/no) 17/7 34/0 0.001
Ocular dryness (yes/no) 17/7 25/9 N.S.
Hyposalivation (yes/no) 18/6 20/14 N.S.
Keratoconjunctivitis sicca (yes/no) 19/5 16/18 0.016
Anti-SSA positive (yes/no) 24/0 4/30 <0.0001
Focus score ≥ 1.0 (yes/no) 6/18 0/34 0.003
UWS (ml/min)* 0.04 (0–0.39) 0.07 (0–0.37) N.S.
SWS (ml/min)* 0.46 (0.08–2.34) 0.78 (0.05–1.72) N.S.
DMF-T* 17 (3–23) 15 (1–24) N.S.
DT* 1 (0–7) 1 (0–5) N.S.
MT* 1 (0–11) 1.0 (0–13) N.S.
FT* 12 (1–21) 12 (1–23) N.S.
DMF-S* 39 (3–112) 46 (1–118) N.S.
Plaque index* 2.30 (0.20–11.20) 2.50 (0.50–6.00) N.S.
Gingival index* 2.80 (0.70–5.80) 2.40 (0.50–8.00) N.S.
Periodontal pocket depth* 2.20 (1.90–3.50) 2.30 (1.90–3.30) N.S.
§Given as mean ± standard deviation. *Given as median (range). UWS; unstimulated whole saliva flow rate, SWS; stimulated whole saliva
flow rate, DMF-T; decayed-missing-filled-teeth, DT; decayed teeth, MT; missing teeth, FT; filled teeth, DMF-S; decayed-missing-filled-
surfaces (five surfaces per tooth). Hyposalivation: UWS ≤ 0.1 ml/min.
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medication or polypharmacy (≥5 prescribed medica-
tions)[28]. Furthermore, there was no difference in oral
health status in terms of UWS and SWS flow rates, DMF-
T/-S, dental plaque, gingival inflammation or periodontal
pocket depth. The non-pSS group had a median UWS
flow rate below the cut-off value (0.07 ml/min) and
a median SWS flow rate just above the cut-off value
(0.78 ml/min). However, the non-pSS group displayed
great inter-individual variations in saliva flow rates (Table
1). There was no difference with regard to the presence of
hyposalivation, but xerostomia wasmore prevalent in the
non-pSS group than the pSS group (P = 0.001).
NGS data
A total number of 1,404,081 sequences with a mean
number of 24,208 (range 7,726–40,739) passed the
quality control, from which a mean percentage of
reads given at genus level was 99.9% (99.7–100%),
while 98.6% (95.7–99.9%) could be identified at the
species level. Less than 0.1% of the reads remained
unassigned. In total, 509 different taxa were identi-
fied at the species level with a mean of 128 (range
33–213) bacterial taxa per sample. The predomi-
nant bacterial genera identified in both the pSS
and non-pSS groups included Streptococcus,
Prevotella, Veillonella and Neisseria, comprising
72% of the salivary microbiota (Figure 1(a)).
There were no statistically significant differences
between the pSS and non-pSS group in terms of
the composition of bacterial genera and species
(Figure 1(a–d)) and bacterial diversity (Shannon
index 3.2 and 3.3, respectively, and P = 0.233).
Discussion
In the present study, there were no differences between
the two groups in terms of age, gender, general health,
intake of xerogenic medication, oral health status, saliva
flow rates and presence of hyposalivation. However, the
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Figure 1. Comparative analysis on group level based on data from HOMINGS. (a) Mean relative abundance of the 15 most
predominant bacterial genera in each group. (b) Mean relative abundance of the bacterial species comprising >1% of the total
microbiota from all 58 samples. (c) Principal component analysis, where axes are expressed as the two most decisive
components accounting for a total of 41.7% of the variation in the dataset. (d) Correspondence analysis, where axes are
expressed as the two most decisive inertias accounting for a cumulative inertia of 21.7%.
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non-pSS patients reported significantly more xerosto-
mia than the patients with pSS. This may be ascribed to
a higher prevalence of polypharmacy in this group,
although not statistically significant. Our findings sug-
gest that the cut-off value for hyposalivation at 0.1 ml/
min can not be used to distinguish patients with pSS
from non-pSS patients with Sjögren–like symptoms, as
both groups had a median UWS below 0.1 ml/min
(0.04 vs. 0.07 ml/min, respectively). Seventy-five
per cent of the patients with pSS and 59% of the non-
pSS patients had a UWS ≤ 0.1 ml/min, giving a low
sensitivity at 47% and a specificity at 70%.
In this study, the patients with pSS and the non-
pSS patients did not differ with regard to caries
experience (DMF-T) or active caries lesions. In gen-
eral, the number of active caries lesions was low,
which may be ascribed to regular dental follow-up
visits and regular daily use of fluoride-containing
toothpaste in both groups. At the time of inclusion
and examination, no specific dental preventive inter-
ventions had been initiated, as the patients were
under diagnostic work-up for pSS, and thus the diag-
nosis was not finally confirmed.
A low incidence of active caries lesions in patients
with pSS has been reported in previous studies as well
[7,11,14], but also an association between pSS and
a high incidence of dental caries [8,17,29–31].
A number of studies have shown a higher DMF-T
score in patients with pSS than in healthy control
subjects [7,9,11], indicating a high previous preva-
lence of caries. The DMF-T/-S indices provide solid
and valid data on dental caries and are widely used,
but also reflect a historical tradition of dental treat-
ments. Thus, the implementation of prevention-
oriented school health program several decades ago,
the improved oral health behaviour, the regular use of
fluoride, and the minimal invasive approach towards
dental restorative treatment and indications for den-
tal extractions are also seen in the DMF-T/-S scores
of patients with pSS. Consequently, in this study, the
mean number of DMF-S in the pSS group was 44 in
contrast to 83 in a comparable study from 2005 [7].
The predominant bacterial genera identified in
both the pSS and the non-pSS group included
Streptococcus, Prevotella, Veillonella and Neisseria,
comprising over 70% of the salivary microbiota.
Thus, the composition of the salivary microbiota
did not differ significantly between the two patient
groups. These findings indicate that the salivary
microbiota is not determined by the underlying dis-
ease of pSS per se, which are in line with the findings
of a recent study by van der Meulen et al. [20]. In this
study, the authors also suggest that reduced salivary
flow is a determinant for a bacterial shift [20], but
this is in contrast to another study indicating that the
dental health status, rather than saliva flow rates,
determines the salivary microbiota [21].
Other studies have shown that pSS is associated with
a reduced bacterial diversity [11,18,32], but these findings
are based on comparison to healthy control subjects.
In this study, we found no statistically significant
difference in the relative abundance of Streptococcus
species, which is in accordance with the findings of
a recent study [11]. However, findings are conflicting,
showing both lower [20] and higher proportions of
Streptococcus species in patients with pSS [18,33], and
none of these studies included measures on oral and
dental health.
We have previously demonstrated that local dis-
ease can influence the salivary microbiota [34–36],
which underlines the importance of recording oral
and dental health status in relation to the interpreta-
tion of data on the oral and salivary microbiota.
Interestingly, none of the studies using the NGS
technique found statistically significant differences of
the cariogenic bacteria S. mutans and Lactobacillus
species in saliva or oral washing in relation to pSS
[11,18,20,32]. This questions the findings of previous
studies using culture-based techniques, and indicates
that selective multiplication of non-abundant species
and genera might be misleading.
This study did not include a healthy control group,
as the aim was to investigate whether patients with pSS
have a distinct salivary microbiota distinguishing them
from patients having Sjögren-like symptoms. Ideally,
this can be useful in the diagnostic work-up and in the
choice of the following therapeutic intervention.
In the future, it would be obvious to conduct
a longitudinal study including a larger cohort of patients
to investigate whether the salivary microbiota changes
over time due to changes in bacterial activity, and if
changes are related to oral and general disease state in
pSS. Such a study would also enable assessment of the
risk of developing oral disease in relation to pSS and
hyposalivation. To assess the risk of developing caries,
it would also be valuable to collect supragingival plaque
samples from various sites in addition to whole saliva.
A potential limitation of using stimulated whole saliva is
that local oral bacteria are diluted when they become
planktonic in saliva. Consequently, a bacterial shift of
specific pathogenic bacteria might be discovered in
a later stage in saliva than in a plaque sample. We have
previously shown that local bacterial alterations in rela-
tion to oral hygiene discontinuation and non-surgical
periodontal treatment are reflected in saliva [37,38], but
the participants all had normal saliva flow rates. To the
best of our knowledge, it remains to be demonstrated
that the composition of the salivary microbiota reflects
local bacterial alterations in patients with severe hyposa-
livation. Consequently, it may be questioned whether
there are differences in the shedding of oral bacteria
from oral sites related to the secretion of saliva from
the various salivary glands. It may be speculated that
bacteria are more adherent to oral surfaces in patients
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with pSSwithmarkedly reduced salivary secretion as well
as in patients with hyposalivation of other causes, and
thus the saliva sample does not sufficiently reflect the
bacterial composition and diversity in the oral cavity.
Therefore, future studies of the salivary microbiota in
patients with pSS should ideally also include local micro-
bial samples.
In conclusion, the composition of the salivary
microbiota did not differ between patients with pSS
and non-pSS patients, nor did oral health status and
saliva flow rates.
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